Fetal patas monkeys sustain mitochondrial toxicity as a result of in Utero zidovudine exposure

Annals of the New York Academy of Sciences

Volumn 918, Issue , 2000, Pages 269-281

  Gerschenson, M ^a   Poirier, M C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DNA DEGRADATION; DNA REPLICATION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME ASSAY; FETOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MITOCHONDRIAL MYOPATHY; MONKEY; NONHUMAN; PRENATAL EXPOSURE; VIRUS TRANSMISSION;

EID: 0033637571     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05496.x     Document Type: Conference Paper

References (33)

1. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine (AZT)
2. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
3. Mitochondrial toxicity of antiviral nucleosides used in AIDS: Insights derived from toxic changes observed in tissues rich in mitochondria
4. Clinical toxicity of antiretroviral nucleoside analogs
5. Zidovudine-associated myopathy
6. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion
7. Mitochondrial myopathy caused by long-term zidovudine therapy
8. Dilated cardiomyopathy in a zidovudine-treated AIDS patient
9. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
10. The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction
11. AZT-induced mitochondrial myopathy
12. Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction
13. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection
14. Early features of zidovudine-associated myopathy: Histopathological findings and clinical correlations
15. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine
16. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus
17. Reversible cardiac dysfunction associated with zidovudine exposure in HIV-infected children
18. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
19. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero
20. Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: Identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity
21. Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): Tumorigenicity in mice and genotoxicity in mice and monkeys
22. Incorporation of 3'-azido-3'-deoxythymidine (AZT) into fetal DNA, and fetal tissue distribution of drug, after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose
23. Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine
24. Persistence, gestation stage-dependent formation and interrelationship of benzo[a]pyrene-induced DNA adducts in mothers, placentae and fetuses of Erythrocebus patas monkeys
25. Molecular phylogeny of macaques: Implications of nucleotide sequences from an 896-base pair region of mitochondrial DNA
26. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines
27. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
28. Cytochemistry and immunocytochemistry of mitochondria in tissue sections
29. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria
30. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells